Skip to main content
Defiance International

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.

In vitro record. Biogerontology, 2025.

  • Cell
  • 2025

Authorship

Exact sentences from the abstract. No machine-written text is on this page. No person reviewed it.

Source: the abstract of PMID 40908429. Checked Verification: Evidence verified by machine against declared source

This study and its findings belong to the authors cited. Defiance International, a supplier of chemical sequences for research use, keeps this record and makes no claim from its findings.

Verify a lot

Evidence verified by machine against declared source

Open declared source

Key facts

Design
Not reported
System
Cell
Scale
Not reported
Comparator
Present
Journal
Biogerontology
Year
2025
PMID
40908429
Verification
Evidence verified by machine against declared source The stored extraction was checked against its declared source. Public summary availability is separate. No tier is an endorsement, an evidence-strength rating, or independent replication, and none establishes efficacy, safety, or suitability.
Full-text availability
Abstract only

Technical summary

Research question

To test epitalon on primary cells, IBR.3 was treated with 1 μg/ml for four days.

Study design

There were several limitations of our work, the main one being that this was an in vitro study using human cell lines in 2D cell cultures.

Participants or experimental system

Human 21NT breast cancer cells were cultured in 1 × Modified Eagle’s medium alpha (alpha MEM) (Gibco), 2.8 μM hydrocortisone, 1 μg/ml insulin, 10% foetal calf serum (FCS), 1% gluta- max, 10 mM HEPES, 0.1 mM NEAA and 12.5 ng/ml Epithelial Growth Factor (EGF).

Intervention or exposure

Breast cancer cells (21NT and BT474) were treated daily with (0.1, 0.2, 0.5, and 1.0 μg/mL) of epitalon for 4 days.

Comparator

Untreated cells were included to serve as a baseline control.

Outcomes examined

Protein from the 21NT, BT474, HMEC and IBR.3 cells were extracted using the TRAPeze 1 × CHAPS lysis buffer (S7705, Millipore) and quantified using the CB-X protein assay kit (G-Bioscience).

Key findings

In this article, the breast cancer cell lines 21NT, BT474, and normal epithelial and fibroblast cells were treated with epitalon then DNA, RNA, and proteins were extracted. qPCR and Immunofluorescence analysis demonstrated dose-dependent telomere length extension in normal cells through hTERT and telomerase upregulation.

Not reported in the declared source: Methods, Study scale.

Limitations and uncertainty

It is important to note that the qPCR method used measures average telomere lengths across all chromosomes, which represents a limitation of the actual technique.

Cite

Cite the study

Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.
Al-Dulaimi S, Thomas R, Matta S et al. Biogerontology. 2025. PMID 40908429

The study and its abstract belong to their authors and publisher. Cite them for anything the study found.

Report an error

If a sentence on this record does not match the abstract, tell us which one. A report starts an automatic re-check by machine. No person reads the record first.

The form takes a sentence and your note. It asks for no name and no address, and we store neither. Do not put personal details in the note.

The report form runs in the interactive page. Open this record with scripts enabled to send a report.

Corrections on this record

No correction has been recorded for this record.

Method sheet

No machine-drafted summary is published on this record. Any section shown is the abstract’s own sentence, printed as issued.